开放期刊系统

浅述严重感染和感染性休克的药物治疗法

禹烜 苗(新乡医学院第一附属医院,中国)

摘要

严重感染和感染性休克是各种严重创伤、烧伤、缺氧、再灌注损伤及外科大手术常见的并发症,目前感染性休克的病死率仍高达50%以±0根据循证医学规范医疗措施,有助于改善其临床防治。

关键词

严重感染;感染性休克;治疗;循证医学

全文:

PDF (English)

参考

Phillip DR, Jean MC,Henry M,et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med, 2004, 32(3):858-873.

Rivers E, Nguyen B, Havstad S,et al. Earlygoal-directed therapy in the treat¬ment of severe sepsis and septic shock. N Engl J Med, 2001, 345(19):1368-1377.

Hollenberg SM, Ahrens TS, Astiz ME, et al. Practice parameters for hemody¬namic support of sepsis in adult patients.Crit Care Med, 1999, 27(3):639-660.

Sharshar T, Blanchard A, Paillard M, et al. Circulating vasopressin levels in septic shock. Crit Care Med, 2003,31(6):1752—1758.

Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisoneand fludrocortisone on mortality in patients with septic shock. JAMA, 2002, 288(7):862-871.

Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyper-dynamic septic shock A prospective, ran¬domized, double-blind, single-center study. Crit Care Med, 1999, 27(4): 723-732.

Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med, 2001, 344(10):699-709.

Van den Berghe G, Wouters P, Wee- kers E et al. Intensive insulin therapy in the critically ill patients. N Engl J Med, 2001,345(19):1359-1367.

Finney SJ, Zekveld C, Elia A, et al. Glucose control and mortality in critically ill patients. JAMA, 2003, 290(15):2041-2047.

Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of inten¬sive insulin therapy in the critically ill: Insu¬lin dose versus glycolic control. Crit Care Med, 2003, 31(2):359-366.



DOI: http://dx.doi.org/10.26549/nimp.v1i1.5437

Refbacks

  • 当前没有refback。
版权所有(c)2020 禹烜 苗 Creative Commons License
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。
  • :+65-98550280 QQ:2249355960 :contact@s-p.sg